Precision Medicines
to Genera Therapies, where we harness the power of CRISPR-Cas9 technology to develop innovative tools that transform medicine for humans. Our cutting research in rodent and non-human primate models is dedicated to advancing interventions for infectious diseases, cancer, and hematology.
About us
Genera Therapies, founded by esteemed alumni from Erasmus MC and Harvard, is at the forefront of genetic engineering and modification technology. Our mission is to develop high-quality animal models that facilitate the testing of transformative medicines. With a commitment to innovation and excellence, we strive to contribute significantly to the advancement of biomedical research. Join us in our journey to revolutionize the way therapies are developed and tested.
Our research and management teams bring decades of experience in drug development to create an organization driven to bring treatments from bench to patients.
What we do
Future of Medicines
At Genera Therapies, our novel gene editing and delivery technologies can provide life-long cures to patients suffering the most challenging diseases. Our current pipeline includes development of gene based therapies to potentially potentially curative treatments in oncology, hematology and infectious diseases.
"Nothing great was ever achieved without enthusiasm"
Ralph Waldo Emerson
Get in Touch
Please fill out the contact form for all media, HRÂ and business development inquiries.
One Kendall Square, Cambridge, MA 02139
